Rash Relief Silver
FDA Label NDC 15071-652

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Touchless Care Concepts Llc for the product Rash Relief Silver (NDC 15071-652). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, warnings, directions, inactive ingredients, indications & usage, otc - keep out of reach of children, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Dimethicone             20%       

Petrolatum               25%

Silver                      25 ppm

Purpose

Skin Protectant.

Warnings

- For external use only.

- When using this product do not get into eyes.  If contact occurs, rinse eyes thoroughly with water.  For external use only. 

- Stop use and ask a doctor if condition worsens or does not improve in 7 days.


Directions

- Cleanse the skin area thoroughly. 

- Shake bottle well before use.

- Spray 4-6 inches from skin using firm/quick trigger motion. No rub-in is required.  Coating slowly dries over time.

- Reapply 1-3 times per day or as directed by health professional.


Inactive Ingredients

Cyclomethicone, Hexamethyldisiloxane, Lanolin, Light Mineral Oil, Microcrystalline Wax, Protein, Vitamin A Palmitate, Vitamin D3, Water, White Petrolatum

Indications & Usage

Manage moisture, friction, and inflammation: skin folds, incontinence dermatitis, venous stasis/pressure ulcers, wounds

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.  If swallowed, get medical help or contact a local poison control center immediately.

Package Label.Principal Display Panel

Rrss (Rrss)

Rrss (Rrss)

Enter section text here

* Please review the disclaimer below.